Literature DB >> 12478611

Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.

Lawrence D F Moon1, Richard A Asher, James W Fawcett.   

Abstract

Many chondroitin sulfate proteoglycans (CSPGs) have been shown to influence CNS axon growth in vitro and in vivo. These interactions can be mediated through the core protein or through the chondroitin sulfate (CS) glycosaminoglycan (GAG) side chains. We have shown previously that degrading CS GAG side chains using chondroitinase ABC enhances dopaminergic nigrostriatal axon regeneration in vivo. We test the hypothesis that interfering with complete CSPGs also limit axon growth in vivo. Neurocan, versican, aggrecan, and brevican CSPGs may be anchored within extracellular matrix through binding to hyaluronan glycosaminoglycan. We examine whether degradation of hyaluronan using hyaluronidase might release these inhibitory CSPGs from the extracellular matrix and thereby enhance regeneration of cut nigrostriatal axons. Anesthetized adult rats were given knife cut lesions of the right hemisphere nigrostriatal tract and cannulae were secured transcranially thereby allowing repeated perilesional infusion of saline or saline containing hyaluronidase once daily for 10 days post-axotomy. Eleven days post-transection brains from animals under terminal anesthesia were recovered for histological evaluation. Effective delivery of substance was inferred from the observed reduction in perilesional immunoreactivity for neurocan and versican after treatment with hyaluronidase (relative to saline). Immunolabeling using antibodies against tyrosine hydroxylase was used to examine the response of cut dopaminergic nigral neurons. After transection and treatment with saline, dopaminergic nigral neurons sprouted in a region lacking astrocytes, neurocan and versican. Axons did not regenerate into the lesion surround that contained astrocytes and abundant neurocan and versican. After transection and treatment with hyaluronidase, there was a significant increase in the number of cut dopaminergic nigral axons growing up to 800 microm anterior to the site of transection. However, cut dopaminergic nigral axons still did not regenerate into the lesion surround that contained reduced (albeit residual) neurocan and versican immunoreactivity. Thus, partial degradation of hyaluronan and chondroitin sulfate and depletion of hyaluronan-binding CSPGs enhances local sprouting of cut CNS axons, but long-distance regeneration fails in regions containing residual hyaluronan-binding CSPGs. Hyaluronan, chondroitin sulfate and hyaluronan-binding CSPGs therefore likely contribute toward the failure of spontaneous axon regeneration in the injured adult mammalian brain and spinal cord. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12478611     DOI: 10.1002/jnr.10449

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  17 in total

1.  The effects of proteoglycan surface patterning on neuronal pathfinding.

Authors:  V Hlady; G Hodgkinson
Journal:  Materwiss Werksttech       Date:  2007-12-01       Impact factor: 0.854

2.  Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease.

Authors:  Yasuyuki Nobuhara; Koichiro Usuku; Mineki Saito; Shuji Izumo; Kimiyoshi Arimura; Charles R M Bangham; Mitsuhiro Osame
Journal:  Immunogenetics       Date:  2006-01-10       Impact factor: 2.846

3.  Aggrecan is expressed by embryonic brain glia and regulates astrocyte development.

Authors:  Miriam S Domowicz; Timothy A Sanders; Clifton W Ragsdale; Nancy B Schwartz
Journal:  Dev Biol       Date:  2008-01-22       Impact factor: 3.582

Review 4.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

5.  A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration.

Authors:  Lynn C Usher; Andrea Johnstone; Ali Ertürk; Ying Hu; Dinara Strikis; Ina B Wanner; Sanne Moorman; Jae-Wook Lee; Jaeki Min; Hyung-Ho Ha; Yuanli Duan; Stanley Hoffman; Jeffrey L Goldberg; Frank Bradke; Young-Tae Chang; Vance P Lemmon; John L Bixby
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

6.  Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.

Authors:  Nina Dmitrieva; Lianbo Yu; Mariano Viapiano; Timothy P Cripe; E Antonio Chiocca; Joseph C Glorioso; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2010-12-21       Impact factor: 12.531

7.  Elevated MMP Expression in the MRL Mouse Retina Creates a Permissive Environment for Retinal Regeneration.

Authors:  Budd Tucker; Henry Klassen; Liu Yang; Dong Feng Chen; Michael J Young
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

8.  Laser injury promotes migration and integration of retinal progenitor cells into host retina.

Authors:  Caihui Jiang; Henry Klassen; Xinmei Zhang; Michael Young
Journal:  Mol Vis       Date:  2010-06-04       Impact factor: 2.367

9.  A new in vitro model of the glial scar inhibits axon growth.

Authors:  Ina B Wanner; Andres Deik; Miguel Torres; Andrew Rosendahl; Joseph T Neary; Vance P Lemmon; John L Bixby
Journal:  Glia       Date:  2008-11-15       Impact factor: 7.452

Review 10.  Pharmacologic and chemical adjuvants in tumor virotherapy.

Authors:  Christopher Alvarez-Breckenridge; Balveen Kaur; E Antonio Chiocca
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.